Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer

Akanksha Behl, Subhash Solanki, Shravan K. Paswan, Tirtha K. Datta, Adesh K. Saini, Reena V. Saini, Virinder S. Parmar, Vijay Kumar Thakur*, Shashwat Malhotra, Anil K. Chhillar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
41 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science